Zinzino AB (publ.) cancels warrants that have not been exercised

Zinzino AB (publ.) announces that the company has started the process of canceling all 800,000 warrants in the 2021-01 series with an exercise price of SEK 140 and which expires on 2026-05-31. No warrants in the series have been subscribed to date, whereby the board wishes to create space for the upcoming annual general meeting of the company to decide on new, more attractive incentive programs for key personnel in the external distributor organization and for senior executives in the group.

The scrapping means that the maximum dilution, if all warrants held by warrant holders in the other currently issued warrant programs are exercised and new shares are subscribed, is reduced from approximately 9.2 percent to 6.8 percent of the total number of outstanding shares. For more information on current outstanding option programs please visit www.zinzino.com for more information.

For more information please contact:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, email: dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 707 900 174, email: fredrik.nielsen@zinzino.com

Images for free publication:
marketing@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.